Myeloproliferative Diseases as Possible Risk Factor for Development of Chronic Thromboembolic Pulmonary Hypertension-A Genetic Study.

doi:10.3390/ijms21093339

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Myeloproliferative Diseases as Possible Risk Factor for Development of Chronic Thromboembolic Pulmonary Hypertension-A Genetic Study.

International journal of molecular sciences - 8 May 2020

Eichstaedt Christina A, Verweyen Jeremias, Halank Michael, Benjamin Nicola, Fischer Christine, Mayer Eckhard, Guth Stefan, Wiedenroth Christoph B, Egenlauf Benjamin, Harutyunova Satenik, Xanthouli Panagiota, Marra Alberto M, Wilkens Heinrike, Ewert Ralf, Hinderhofer Katrin, Grünig Ekkehard

Abstract excerpt

Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare disease which is often caused by recurrent emboli. These are also frequently found in patients with myeloproliferative diseases. While myeloproliferative diseases can be caused by gene defects, the genetic predisposition to CTEPH is largely unexplored. Therefore, the objective of this study was to analyse these genes and further genes involved in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone Morphogenetic Protein Receptors, Type II

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chronic Disease

Share to Codon, Nonsense

Share to Hypertension, Pulmonary

Share to Janus Kinase 2

Share to Mutation, Missense

Share to Myeloproliferative Disorders

Share to Pulmonary Embolism

Source

Open in PubMed Open full text

Identifiers

PMID: 32397294
DOI: 10.3390/ijms21093339
PMCID: PMC7246715

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Myeloproliferative Diseases as Possible Risk Factor for Development of Chronic Thromboembolic Pulmonary Hypertension-A Genetic Study.PMID 32397294Read ↗

JAK2 mutation-related disease and thrombosis.Semantic proximity Read ↗

Molecular Research in Chronic Thromboembolic Pulmonary HypertensionSemantic proximity Read ↗

High Frequency of Pulmonary Hypertension-Causing Gene Mutation in Chinese Patients with Chronic Thromboembolic Pulmonary Hypertension.Semantic proximity Read ↗

BMPR2 germline mutation in chronic thromboembolic pulmonary hypertension.Semantic proximity Read ↗

[Pulmonary hypertension: Possible genetic causes and therapeutic options].Semantic proximity Read ↗

Molecular Genetics of Thrombotic Myeloproliferative Neoplasms: Implications in Precision OncologySemantic proximity Read ↗

[Budd-Chiari syndrome and JAK2 gene mutation].Semantic proximity Read ↗

Association of V617F Jak2 mutation with the risk of thrombosis among patients with essential thrombocythaemia or idiopathic myelofibrosis: a systematic review.Semantic proximity Read ↗

Genetics of pulmonary hypertension.Semantic proximity Read ↗

The impact of JAK2V617F mutation on different types of thrombosis risk in patients with essential thrombocythemia: a meta-analysis.Semantic proximity Read ↗

The incidence of the thrombophilic SNPs rs6025, rs1799963, rs2066865, rs2289252, and rs8176719 in chronic thromboembolic pulmonary hypertension.Semantic proximity Read ↗

A systematic review of genetic mutations in pulmonary arterial hypertension.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.